NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle declared a quarterly dividend on Tuesday, October 30th. Investors of record on Friday, December 14th will be given a dividend of $0.335 per share on Wednesday, January 2nd. This represents a $1.34 annualized dividend and a yield of 1.81%. The ex-dividend date of this dividend is Thursday, December 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) announced its quarterly earnings data on Wednesday, November, 7th. The specialty chemicals company reported $1.31 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.25 by $0.06. The specialty chemicals company earned $778 million during the quarter, compared to analyst estimates of $796.79 million. Albemarle had a net margin of 10.44% and a return on equity of 15.39%. Albemarle's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.08 EPS. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Tuesday, February 26th 2019. View Earnings Estimates for Albemarle.

Albemarle issued an update on its FY18 earnings guidance on Wednesday, November, 7th. The company provided earnings per share (EPS) guidance of $5.30-5.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.39. The company issued revenue guidance of $3.3-3.5 billion, compared to the consensus revenue estimate of $3.37 billion.Albemarle also updated its FY 2018 guidance to $5.30-5.50 EPS.

20 equities research analysts have issued 12-month target prices for Albemarle's stock. Their predictions range from $59.00 to $150.00. On average, they expect Albemarle's stock price to reach $114.9795 in the next twelve months. This suggests a possible upside of 55.5% from the stock's current price. View Analyst Price Targets for Albemarle.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 3 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle.

Headlines about ALB stock have trended positive recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Albemarle earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned media stories about the specialty chemicals company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the next few days.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), PolyOne (POL), Rogers (ROG), Trinseo (TSE), Kraton (KRA), AdvanSix (ASIX), Cereplast (CERPQ), A Schulman (SHLM) and ForceField Energy (FNRG).

Albemarle's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include KAMES CAPITAL plc (0.50%), Scout Investments Inc. (0.22%), Personal Capital Advisors Corp (0.16%), Centre Asset Management LLC (0.06%), Beech Hill Advisors Inc. (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including QCI Asset Management Inc. NY, Personal Capital Advisors Corp, Beech Hill Advisors Inc., Centre Asset Management LLC, Intl Fcstone Inc., Louisiana State Employees Retirement System and Gateway Investment Advisers LLC. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was purchased by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, DNB Asset Management AS, New England Research & Management Inc., Virtu Financial LLC, Scout Investments Inc., State of Alaska Department of Revenue, Kistler Tiffany Companies LLC and First Hawaiian Bank. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $73.93.

Albemarle has a market capitalization of $8.17 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

The official website for Albemarle is http://www.albemarle.com.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]